These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 29504704)

  • 1. A Cross-Sectional Study to Assess the Modulation of Wnt Inhibitors following Anti-Epileptic Drug Therapy and their Correlation with Vitamin D and Receptor Activator of Nuclear Factor κ B Ligand in Indian Women with Epilepsy.
    Parveen B; Tripathi M; Vohora D
    Basic Clin Pharmacol Toxicol; 2018 Sep; 123(3):271-276. PubMed ID: 29504704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The anti-epileptic drugs valproate, carbamazepine and levetiracetam cause bone loss and modulate Wnt inhibitors in normal and ovariectomised rats.
    Parveen B; Tiwari AK; Jain M; Pal S; Chattopadhyay N; Tripathi M; Vohora D
    Bone; 2018 Aug; 113():57-67. PubMed ID: 29758362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of body composition in persons with epilepsy on conventional & new antiepileptic drugs.
    Sarangi SC; Tripathi M; Kakkar AK; Gupta YK
    Indian J Med Res; 2016 Mar; 143(3):323-30. PubMed ID: 27241646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of long-term antiepileptic drug monotherapy on vascular risk factors and atherosclerosis.
    Chuang YC; Chuang HY; Lin TK; Chang CC; Lu CH; Chang WN; Chen SD; Tan TY; Huang CR; Chan SH
    Epilepsia; 2012 Jan; 53(1):120-8. PubMed ID: 22085257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monotherapy with Levetiracetam Versus Older AEDs: A Randomized Comparative Trial of Effects on Bone Health.
    Hakami T; O'Brien TJ; Petty SJ; Sakellarides M; Christie J; Kantor S; Todaro M; Gorelik A; Seibel MJ; Yerra R; Wark JD
    Calcif Tissue Int; 2016 Jun; 98(6):556-65. PubMed ID: 26842957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The bone mineral content alterations in pediatric patients medicated with levetiracetam, valproic acid, and carbamazepine.
    Serin HM; Koç ZP; Temelli B; Esen İ
    Epilepsy Behav; 2015 Oct; 51():221-4. PubMed ID: 26298867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Haematological side effects of antiepileptic drug treatment in patients with epilepsy.
    Bachmann T; Bertheussen KH; Svalheim S; Rauchenzauner M; Luef G; Gjerstad L; Taubøll E
    Acta Neurol Scand Suppl; 2011; (191):23-7. PubMed ID: 21711253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors associated with serum soluble inhibitors of Wnt-β-catenin signaling (sclerostin and dickkopf-1) in patients undergoing peritoneal dialysis.
    Yamada S; Tsuruya K; Tokumoto M; Yoshida H; Ooboshi H; Kitazono T
    Nephrology (Carlton); 2015 Sep; 20(9):639-45. PubMed ID: 25974190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of sclerostin/dickkopf-1 and receptor activator of nuclear factor kB ligand/osteoprotegerin signalling pathways in the development of osteoporosis in patients with haemophilia A and B: A cross-sectional study.
    Anagnostis P; Vakalopoulou S; Christoulas D; Paschou SA; Papatheodorou A; Garipidou V; Kokkoris P; Terpos E
    Haemophilia; 2018 Mar; 24(2):316-322. PubMed ID: 29194852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early effects of IL-6 receptor inhibition on bone homeostasis: a pilot study in women with rheumatoid arthritis.
    Terpos E; Fragiadaki K; Konsta M; Bratengeier C; Papatheodorou A; Sfikakis PP
    Clin Exp Rheumatol; 2011; 29(6):921-5. PubMed ID: 22032557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of Wnt/β-catenin and RANKL/OPG in bone healing of diabetic Charcot arthropathy patients.
    Folestad A; Ålund M; Asteberg S; Fowelin J; Aurell Y; Göthlin J; Cassuto J
    Acta Orthop; 2015; 86(4):415-25. PubMed ID: 25811776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased levels of Dickkopf-1 are indicative of Wnt/β-catenin downregulation and lower osteoblast signaling in children and adolescents with type 1 diabetes mellitus, contributing to lower bone mineral density.
    Tsentidis C; Gourgiotis D; Kossiva L; Marmarinos A; Doulgeraki A; Karavanaki K
    Osteoporos Int; 2017 Mar; 28(3):945-953. PubMed ID: 27766367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of topiramate monotherapy on bone mineral density and markers of bone and mineral metabolism in premenopausal women with epilepsy.
    Heo K; Rhee Y; Lee HW; Lee SA; Shin DJ; Kim WJ; Song HK; Song K; Lee BI
    Epilepsia; 2011 Oct; 52(10):1884-9. PubMed ID: 21692779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucocorticoid therapy causes contradictory changes of serum Wnt signaling-related molecules in systemic autoimmune diseases.
    Kawazoe M; Kaneko K; Shikano K; Kusunoki N; Nanki T; Kawai S
    Clin Rheumatol; 2018 Aug; 37(8):2169-2178. PubMed ID: 28551822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fish liver oil and propolis as protective natural products against the effect of the anti-epileptic drug valproate on immunological markers of bone formation in rats.
    Elwakkad AS; El Elshamy KA; Sibaii H
    Epilepsy Res; 2008 Jul; 80(1):47-56. PubMed ID: 18455911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of carbamazepine and valproate on bone metabolism in children with epilepsy].
    Song XQ; Wang ZP; Bao KR; Zhang JM; Wu J; Yan CH; Shen XM
    Zhonghua Er Ke Za Zhi; 2005 Oct; 43(10):728-32. PubMed ID: 16255847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in Dkk-1, sclerostin, and RANKL serum levels following discontinuation of long-term denosumab treatment in postmenopausal women.
    Fassio A; Adami G; Benini C; Vantaggiato E; Saag KG; Giollo A; Lippolis I; Viapiana O; Idolazzi L; Orsolini G; Rossini M; Gatti D
    Bone; 2019 Jun; 123():191-195. PubMed ID: 30910600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vitamin D Deficiency in Ambulant Children on Carbamazepine or Sodium Valproate Monotherapy.
    Sreedharan M; Devadathan K; Mohammed Kunju PA; Sasidharan B; Pillai JP; Vasumathy Amma MA; Muthubeevi S
    Indian Pediatr; 2018 Apr; 55(4):307-310. PubMed ID: 29428922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relationship between inhibitors of the Wnt signalling pathway (sclerostin and Dickkopf-1) and carotid intima-media thickness in postmenopausal women with type 2 diabetes mellitus.
    Gaudio A; Privitera F; Pulvirenti I; Canzonieri E; Rapisarda R; Fiore CE
    Diab Vasc Dis Res; 2014 Jan; 11(1):48-52. PubMed ID: 24227537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of glucocorticoid treatment on Wnt signalling antagonists (sclerostin and Dkk-1) and their relationship with bone turnover.
    Gifre L; Ruiz-Gaspà S; Monegal A; Nomdedeu B; Filella X; Guañabens N; Peris P
    Bone; 2013 Nov; 57(1):272-6. PubMed ID: 23981659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.